Humanigen Inc (HGENQ)

[TRUISM]

Shorts Continue to Pile in KaloBios Pharma (KBIO) Despite Near Death Experience for Early Traders
December 10, 2015 11:48 AM EST
Click For Link



Despite a near death experience for those early on the trade, shorts are still pilling on KaloBios Pharma (NASDAQ: KBIO).

According to the latest data, KBIO short interest rose 26.1% to 46.7% of the float, as highlighted by Jefferies analyst Eun Yang.

After trading below $1, shares of KBIO surged to nearly $46 per shares over the past month after Martin Shkreli bought up 70% of the shares and put the company back on a path to bring its drugs to market. Before Shkreli's involvement the company was expected to be shuttered. Piling on the shorts, Shkreli pulled the borrow on his shares, which created an epic short squeeze.



Blessings to All

TRUTH